This understanding of unique molecular pathway, HPV16 E6/miR-2861/EGFR/AKT2/CCND1, may provide the novel insight into the exploration of additional strategies for cervical cancer therapy in the future. This evidence concerns the gene AKT2 and cervical carcinoma.